PMID: 26959411
Boers-Sonderen M, Mulder SF, Nagtegaal ID, Derikx LA, Wanten G, Mulders P, van der Graaf WT, Hoentjen F, van Herpen CM. Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: is the cause in the mucosa. Acta Oncol. 2016;55(4):444-8.
doi: 10.3109/0284186X.2015.1119883.
PMID: 26969198
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huizen ME, Vredevoogd CB, Brons J, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J; HYPITAT-II Study Group. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). BJOG. 2016 Mar 10. doi: 10.1111/1471-0528.13957. [Epub ahead of print]
PMID: 26970318
Santosaningsih D, Santoso S, Budayanti NS, Suata K, Lestari ES, Wahjono H, Djamal A, Kuntaman K, van Belkum A, Laurens M, Snijders SV, Willemse-Erix D, Goessens WH, Verbrugh HA, Severin JA.
Characterisation of clinical Staphylococcus aureus isolates harbouring mecA or Panton-Valentine leukocidin genes from four tertiary care hospitals in Indonesia. Trop Med Int Health. 2016 May;21(5):610-8. doi:
10.1111/tmi.12692. Epub 2016 Mar 30.
PMID: 26972764
Hulsen DJ, Geurts J, van Gestel NA, van Rietbergen B, Arts JJ. Mechanical behaviour of Bioactive Glass granules and morselized cancellous bone allograft in load bearing defects. J Biomech. 2016 May 3;49(7):1121-7.
PMID: 26973841
Boulaksil M, Bierhuizen MF, Engelen MA, Stein M, Kok BJ, van Amersfoorth SC, Vos MA, van Rijen HV, de Bakker JM, van Veen TA. Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats. Front Cardiovasc Med. 2016 Mar 2;3:5. doi: 10.3389/fcvm.2016.00005. eCollection 2016.
PMID: 26984911
Delawi D, Jacobs W, van Susante JL, Rillardon L, Prestamburgo D, Specchia N, Gay E, Verschoor N,
Garcia-Fernandez C, Guerado E, Quarles van Ufford H, Kruyt MC, Dhert WJ, Oner FC. OP-1 Compared with
Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial. J
Bone Joint Surg Am. 2016 Mar 16;98(6):441-8. doi: 10.2106/JBJS.O.00209.
PMID: 26989852
Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Ossenkoppele PM, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM. Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry. Br J Dermatol. 2016 Aug;175(2):340-7. doi: 10.1111/bjd.14552. Epub 2016 Jun 25.
PMID: 26991464
Ebisch RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, IntHout J, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Bulten J, Siebers AG, Bekkers RL, Melchers WJ. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples. Int J Cancer. 2016 Aug 1;139(3):691-9. doi: 10.1002/ijc.30090. Epub 2016 Apr 7.
PMID: 26992110
Derikx LA, Vierdag WM, Kievit W, Bosch S, Hoentjen F, Nagtegaal ID. Increased prevalence of colonic neuroendocrine tumors in inflammatory bowel disease. Int J Cancer. 2016 Aug 1;139(3):535-42. doi:
10.1002/ijc.30096. Epub 2016 Apr 4.
PMID: 26995271
Willemsen AE, Lubberman FJ, Tol J, Gerritsen WR, van Herpen CM, van Erp NP. Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors. Drug Discov Today. 2016 Jun;21(6):962-76. doi: 10.1016/j.drudis.2016.03.002. Epub 2016 Mar 17. Review.
PMID: 27005591
De Bruin JL, Karthikesalingam A, Holt PJ, Prinssen M, Thompson MM, Blankensteijn JD; Dutch Randomised Endovascular Aneurysm Management (DREAM) Study Group. Bak AA, Buth J, Pattynama PM, Verhoeven EL, van Voorthuisen AE, Blankensteijn JD, Balm R, Buth J, Cuypers PW, Grobbee DE, Prinssen M, van Sambeek MR, Verhoeven EL, Baas AF, Hunink MG, van Engelshoven JM, Jacobs MJ, de Mol BA, van Bockel JH, Balm R, Reekers J, Tielbeek X, Verhoeven EL, Wisselink W, Boekema N, Heuveling LM, Sikking I, Prinssen M, Balm R, Blankensteijn JD, Buth J, Cuypers PW, van Sambeek MR, Verhoeven EL, de Bruin JL, Baas AF, Blankensteijn JD, Prinssen M, Buth J, Tielbeek AV, Blankensteijn JD, Balm R, Reekers JA, van Sambeek MR, Pattynama P, Verhoeven EL, Prins T, van der Ham AC, van der Velden JJ, van Sterkenburg SM, Ten Haken GB, Bruijninckx CM, van Overhagen H, Tutein Nolthenius RP, Hendriksz TR, Teijink JA, Odink HF, de Smet AA, Vroegindeweij D, van Loenhout RM, Rutten MJ, Hamming JF, Lampmann LE, Bender MH, Pasmans H, Vahl AC, de Vries C, Mackaay AJ, van Dortmont LM, van der Vliet AJ, Schultze Kool LJ, Boomsma JH, van HR, de Mol van Otterloo JC, de Rooij TP, Smits TM, Yilmaz EN, Wisselink W, van den Berg FG, Visser MJ, van der Linden E, Schurink GW, de Haan M, Smeets HJ, Stabel P, van Elst F, Poniewierski J, Vermassen FE. Predicting reinterventions after open and endovascular aneurysm repair using the St George’s Vascular Institute score.
J Vasc Surg. 2016 Jun;63(6):1428-1433. doi: 10.1016/j.jvs.2015.12.028.
189 BIJLAGE WETENSCHAPPELIJKE PUBLICATIES 2013-2014 OPGENOMEN IN PUBMED
PMID: 27027209
Groothuis JT, van Eijk JJ, van de Laar FA, van Alfen N [Incidence of neuralgic amyotrophy in a primary care setting: a prospective cohort study]. Ned Tijdschr Geneeskd. 2015;160:A9957. Dutch.
PMID: 27048897
Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):55-71. doi: 10.1016/j.bpg.2016.02.005. Epub 2016 Feb 9.
PMID: 27048744
Leenders AC. Prevention of Surgical Site Infections: Universal Decontamination Not for All, but for a Selection of Surgical Patients. Clin Infect Dis. 2016 Jun 1;62(11):1469-70. doi: 10.1093/cid/ciw214. Epub 2016 Apr 5. No abstract available.
PMID: 27049170
Stam H, Harting T, Sluijs Mv, Marum Rv, Horst Hv, Wouden JC, Maarsingh OR. Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch general practice. Scand J Prim Health Care. 2016 Jun;34(2):165-71. doi: 10.3109/02813432.2016.1160634. Epub 2016 Apr 6.
PMID: 27050045
Korterink JJ, Ockeloen LE, Hilbink M, Benninga MA, Deckers-Kocken JM. Yoga Therapy for Abdominal Pain Related-Functional Gastrointestinal Disorders in Children. A Randomized Controlled Trial. J Pediatr Gastroenterol Nutr. 2016 Apr 4. [Epub ahead of print]
PMID: 27055805
Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, Girard M, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Sola P, Shaygannejad V, Hupperts R, Alroughani R, Oreja-Guevara C, Pucci E, Boz C, Lechner-Scott J, Bergamaschi R, Van Pesch V, Iuliano G, Ramo C, Taylor B, Slee M, Spitaleri D, Granella F, Verheul F, McCombe P, Hodgkinson S, Amato MP, Vucic S, Gray O, Cristiano E, Barnett M, Sanchez Menoyo JL, van Munster E, Saladino ML, Olascoaga J, Prevost J, Deri N, Shaw C, Singhal B, Moore F, Rozsa C, Shuey N, Skibina O, Kister I, Petkovska-Boskova T, Ampapa R, Kermode A, Butzkueven H, Jokubaitis V, Kalincik T; MSBase Study Group. Contribution of different relapse phenotypes to disability in multiple sclerosis. Mult Scler. 2016 Apr 7. pii: 1352458516643392.
PMID: 27059152
de Bruin JL, Groenwold RH, Baas AF, Brownrigg JR, Prinssen M, Grobbee DE, Blankensteijn JD; DREAM
Study Group. Bak AA, Buth J, Pattynama PM, Verhoeven EL, van Voorthuisen AE, Blankensteijn JD, Balm R,
Buth J, Cuypers PW, Grobbee DE, Prinssen M, van Sambeek MR, G Verhoeven EL, Baas AF, Hunink MG, van
Engelshoven JM, Jacobs MJ, de Mol BA, van Bockel JH, Balm R, Reekers J, Tielbeek X, Verhoeven EL,
Wisselink W, Boekema N, Heuveling I Sikking LM, Prinssen M, Balm R, Blankensteijn JD, Buth J, Cuypers PW,
van Sambeek MR, Verhoeven EL, de Bruin JL, Baas AF, Blankensteijn JD, Prinssen M, Buth J, Tielbeek AV,
Blankensteijn JD, Balm R, Reekers JA, van Sambeek MR, Pattynama P, Verhoeven EL, Prins T, van der Ham
AC, van der Velden JJ, van Sterkenburg SM, Ten Haken GB, Bruijninckx CM, van Overhagen H, Tutein
Nolthenius RP, Hendriksz TR, Teijink JA, Odink HF, de Smet AA, Vroegindeweij D, van Loenhout RM, Rutten
MJ, Hamming JF, Lampmann LE, Bender MH, Pasmans H, Vahl AC, de Vries C, Mackaay AJ, van Dortmont
LM, van der Vliet AJ, Schultze Kool LJ, Boomsma JH, van Dop HR, de Mol van Otterloo JC, de Rooij TP, Smits TM, Yilmaz EN, Wisselink W, van den Berg Vrije FG, Visser MJ, van der Linden E, Schurink GW, de Haan M, Smeets HJ, Stabel P, van Elst F, Poniewierski J, Vermassen FE. Quality of life from a randomized trial of open and endovascular repair for abdominal aortic aneurysm. Br J Surg. 2016 Jul;103(8):995-1002. doi:
10.1002/bjs.10130.
PMID: 27059387
Mourits MM, Nijhof WH, van Leuken MH, Jager GJ, Rutten MJ. Reducing contrast medium volume and kilo voltage in CTA of the pulmonary artery. Clinical Radiology 2016 Jun;71(6):615.e7-615.e13.
doi: 10.1016/j.crad.2016.03.005.
AIM: To evaluate image quality after contrast medium (CM) and tube voltage reduction in computed tomography angiography (CTA) of the pulmonary artery. MATERIALS AND METHODS: Thirty-three patients referred for CTA of the pulmonary artery for suspected pulmonary embolism were included. Patients were randomly assigned to Protocol I (100 ml of 350 mg iodine/ml iodinated CM; n=16) or Protocol II (50 ml of 350 mg iodine/ml iodinated CM; n=17).
Dual-energy CT (80 kV and 140 kV) was performed in all patients. An averaged weighted series equivalent to a 120 kV image acquisition was reconstructed. The mean attenuation value of CM was measured at eight positions in the pul-monary trunk and pulpul-monary arteries. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated.
Qualitative assessment of the vascular enhancement was performed independently by two experienced radiologists using a three-point scale. Mean attenuation values, image noise, CNR, and SNR of images with 50 ml CM and images with 100 ml CM were compared and mean attenuation values, image noise, CNR, and SNR in 80 kV images and 120 kV images were compared. For qualitative analysis, interobserver variability was analysed using Cohen’s kappa statistics. RESULTS: The mean attenuation values in Protocol I and Protocol II were not significantly different at 80 kV (634.6±168.3 versus 537.9±146.7 HU; p=0.088) and 120 kV (482.8±127.7 versus 410.4±106.0 HU; p=0.085). The mean attenuation value at 80 kV was significantly higher than the mean attenuation value at 120 kV in Protocols I and II (p<0.001). The CNR and SNR were higher at 120 kV than at 80 kV in both protocols (p=0.000-0.019); however, there were no significant differences in the CNR and SNR between both protocols (p=0.600-0.952). Qualitative (sub-jective) analysis showed no statistical significant difference between Protocols I and II (p=0.524-1.000). CONCLUSION:
Low tube voltage (80 kV) CTA using 50 ml CM is not inferior to CTA at 120 kV using 100 ml CM.
PMID: 27067656
Osterthun R, van Asbeck FW, Nijendijk JH, Post MW. In-hospital end-of-life decisions after new traumatic spinal cord injury in the Netherlands. Spinal Cord. 2016 Apr 12. doi: 10.1038/sc.2016.37. [Epub ahead of print]
STUDY DESIGN: Explorative retrospective files study. OBJECTIVES: To document end-of-life decisions (ELDs) in in-hospital deaths after new traumatic spinal cord injury (TSCI). SETTING: The Netherlands. METHODS: Discharge letters concerning patients with TSCI discharged from Dutch acute hospitals in 2010 were analysed. Data were extracted on survival, personal and lesion characteristics, comorbidities, other injuries, preexisting spinal stenosis, stabilising surgery, length of hospital stay and the presence and types of ELDs. Characteristics of deceased patients and survivors were compared using κ2 and T-tests. Characteristics of the deceased patients and ELDs were further explored. RESULTS: A total of 185 patients with new TSCI were identified. Twenty-six patients were excluded as their survival status at discharge was unknown-for example, because of discharge to another hospital without information about their final discharge. Thirty of the remaining 159 patients died during their initial hospital stay (18.9%). Deceased patients were older and had more often high cervical and motor complete injuries than survivors. The circumstances
191 BIJLAGE WETENSCHAPPELIJKE PUBLICATIES 2013-2014 OPGENOMEN IN PUBMED
of death were sparsely documented, and in nine cases, it was not possible to determine the absence or the presence of an ELD. ELDs were reported in 19 deaths (63.3%). All were non-treatment decisions, and almost all (89.5%) were decisions of withdrawal of treatment. There were no cases of documented euthanasia or physician-assisted suicide.
CONCLUSION: ELDs were reported in the majority of in-hospital deaths after new TSCI in the Netherlands (63.3%), and all were non-treatment decisions.